A. Alexander

发表

Thresholding in PET images of static and moving targets

B. Murray, B. Yaremko, W. Roa, 2005, Physics in medicine and biology.

Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.

B. Murray, W. Roa, A. Murtha, 2006, Clinical and investigative medicine. Medecine clinique et experimentale.

Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir.

P. Truong, A. Alexander, C. Ludgate, 2011, International journal of radiation oncology, biology, physics.

Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial.

J. Crook, H. Pai, P. Truong, 2010, International journal of radiation oncology, biology, physics.

Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer.

G. Duncan, S. Tyldesley, V. Lapointe, 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Comparing Deep Learning-based Auto-segmentation of Organs at Risk and Clinical Target Volumes to Expert Inter-Observer Variability in Radiotherapy Planning

N. McVicar, D. Wells, A. Alexander, 2019, International Journal of Radiation Oncology*Biology*Physics.

Biochemical Response is More Critical than Total Duration of Neo-adjuvant Hormone Therapy (NAHT) Prior to Radiotherapy for Localized Prostate Cancer: Analysis of the 3 vs 8 Month Data

J. Crook, M. Lesperance, A. Alexander, 2008 .

Stereotactic ablative radiation therapy with volumetric modulated arc therapy in flattening filter-free mode for low-, intermediate-, and high-risk prostate cancer patients: Are 2 arcs better than 1?

A. Mestrovic, A. Alexander, D. Fortin, 2015, Practical radiation oncology.

A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion.

S. Tyldesley, M. Mckenzie, K. Chi, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2022, JAMA oncology.

Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy

J. Lum, Julian J. Lum, A. Alexander, 2017, Cancers.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

Maximizing rectal dose sparing with hydrogel: A retrospective planning study

I. Gagne, H. Pai, A. Alexander, 2019, Journal of applied clinical medical physics.

Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.

I. Olivotto, P. Truong, H. Kader, 2009, International journal of radiation oncology, biology, physics.

Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning.

Lovedeep Gondara, Carter Kolbeck, Jordan Wong, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy.

Sunita Ghosh, W. Roa, A. Murtha, 2011, Anticancer research.

Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers

K. Otto, E. Saibishkumar, D. Wells, 2021, Radiation oncology.

Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers

K. Otto, E. Saibishkumar, D. Wells, 2021, Radiation Oncology.

Prospective Evaluation of a 12-Week Walking Exercise Program and Its Effect on Fatigue in Prostate Cancer Patients Undergoing Radical External Beam Radiotherapy

P. Truong, A. Alexander, C. Gaul, 2011, American journal of clinical oncology.

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

I. Gagne, A. Alexander, O. Paetkau, 2020, Journal of applied clinical medical physics.

Progression-free survival and local control following stereotactic ablative radiotherapy for up to 5 oligometastases: an analysis from the population-based phase II SABR-5 trial.

N. Chng, S. Tyldesley, Mengxing Liu, 2022, International journal of radiation oncology, biology, physics.

Subventricular Zone Radiation Dose and Outcome for Glioblastoma Treated Between 2006 and 2012

M. Lesperance, P. Truong, A. Alexander, 2018, Cureus.

Neoadjuvant hormone therapy and external beam radiation for localized prostate cancer: Vancouver Island Cancer Centre experience.

K. Wilson, A. Alexander, C. Ludgate, 2000, The Canadian journal of urology.

Post‐implant computed tomography–magnetic resonance prostate image registration using feature line parallelization and normalized mutual information

Ron S. Sloboda, Sandra Vidakovic, Hans S. Jans, 2007, Journal of applied clinical medical physics.

Prospective Evaluation of a 12-Week Walking Exercise Program and Its Effect on Fatigue in Prostate Cancer Patients Undergoing Radical External Beam Radiotherapy

P. Truong, A. Alexander, C. Gaul, 2011, American journal of clinical oncology.